BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 29486782)

  • 41. Dose-painting intensity-modulated proton therapy for intermediate- and high-risk meningioma.
    Madani I; Lomax AJ; Albertini F; Trnková P; Weber DC
    Radiat Oncol; 2015 Mar; 10():72. PubMed ID: 25890217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The first investigation of the dosimetric perturbations from the spot position errors in spot-scanning arc therapy (SPArc).
    Liu P; Zhao L; Liu G; Cong X; Li X; Ding X
    Phys Med Biol; 2024 Jun; 69(13):. PubMed ID: 38870996
    [No Abstract]   [Full Text] [Related]  

  • 43. Robust optimization in intensity-modulated proton therapy to account for anatomy changes in lung cancer patients.
    Li H; Zhang X; Park P; Liu W; Chang J; Liao Z; Frank S; Li Y; Poenisch F; Mohan R; Gillin M; Zhu R
    Radiother Oncol; 2015 Mar; 114(3):367-72. PubMed ID: 25708992
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclotron and linear accelerator generated scanning proton beams for lung cancer SBRT: Interplay effects and mitigations.
    Liu CW; Kolano AM; Gray T; Stephans KL; Videtic GMM; Farr JB; Xia P
    Med Phys; 2024 Jun; 51(6):3985-3994. PubMed ID: 38683935
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study.
    Jeter MD; Gomez D; Nguyen QN; Komaki R; Zhang X; Zhu X; O'Reilly M; Fossella FV; Xu T; Wei X; Wang H; Yang W; Tsao A; Mohan R; Liao Z
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):730-737. PubMed ID: 29248169
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Towards the clinical implementation of intensity-modulated proton therapy for thoracic indications with moderate motion: Robust optimised plan evaluation by means of patient and machine specific information.
    Ribeiro CO; Visser S; Korevaar EW; Sijtsema NM; Anakotta RM; Dieters M; Both S; Langendijk JA; Wijsman R; Muijs CT; Meijers A; Knopf A
    Radiother Oncol; 2021 Apr; 157():210-218. PubMed ID: 33545257
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dosimetric benefits of robust treatment planning for intensity modulated proton therapy for base-of-skull cancers.
    Liu W; Mohan R; Park P; Liu Z; Li H; Li X; Li Y; Wu R; Sahoo N; Dong L; Zhu XR; Grosshans DR
    Pract Radiat Oncol; 2014; 4(6):384-91. PubMed ID: 25407859
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of robustness against setup uncertainties using probabilistic scenarios in lung cancer: a comparison of proton with photon therapy.
    Teoh S; George B; Fiorini F; Vallis KA; Van den Heuvel F
    Br J Radiol; 2020 Mar; 93(1107):20190584. PubMed ID: 31977241
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advanced pencil beam scanning Bragg peak FLASH-RT delivery technique can enhance lung cancer planning treatment outcomes compared to conventional multiple-energy proton PBS techniques.
    Wei S; Lin H; Isabelle Choi J; Shi C; Simone CB; Kang M
    Radiother Oncol; 2022 Oct; 175():238-247. PubMed ID: 35961583
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Towards FLASH proton therapy: the impact of treatment planning and machine characteristics on achievable dose rates.
    van de Water S; Safai S; Schippers JM; Weber DC; Lomax AJ
    Acta Oncol; 2019 Oct; 58(10):1463-1469. PubMed ID: 31241377
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment planning and 4D robust evaluation strategy for proton therapy of lung tumors with large motion amplitude.
    Taasti VT; Hattu D; Vaassen F; Canters R; Velders M; Mannens J; van Loon J; Rinaldi I; Unipan M; van Elmpt W
    Med Phys; 2021 Aug; 48(8):4425-4437. PubMed ID: 34214201
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A dosimetric comparison of intensity-modulated proton therapy optimization techniques for pediatric craniopharyngiomas: a clinical case study.
    Yeung D; McKenzie C; Indelicato DJ
    Pediatr Blood Cancer; 2014 Jan; 61(1):89-94. PubMed ID: 24000229
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel energy sequence optimization algorithm for efficient spot-scanning proton arc (SPArc) treatment delivery.
    Liu G; Li X; Zhao L; Zheng W; Qin A; Zhang S; Stevens C; Yan D; Kabolizadeh P; Ding X
    Acta Oncol; 2020 Oct; 59(10):1178-1185. PubMed ID: 32421375
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dosimetric comparison of flattened and unflattened beams for stereotactic ablative radiotherapy of stage I non-small cell lung cancer.
    Hrbacek J; Lang S; Graydon SN; Klöck S; Riesterer O
    Med Phys; 2014 Mar; 41(3):031709. PubMed ID: 24593713
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Robust optimization to reduce the impact of biological effect variation from physical uncertainties in intensity-modulated proton therapy.
    Bai X; Lim G; Grosshans D; Mohan R; Cao W
    Phys Med Biol; 2019 Jan; 64(2):025004. PubMed ID: 30523932
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC.
    Giaddui T; Chen W; Yu J; Lin L; Simone CB; Yuan L; Gong YU; Wu QJ; Mohan R; Zhang X; Bluett JB; Gillin M; Moore K; O'Meara E; Presley J; Bradley JD; Liao Z; Galvin J; Xiao Y
    Radiat Oncol; 2016 May; 11():66. PubMed ID: 27142674
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Integrated beam orientation and scanning-spot optimization in intensity-modulated proton therapy for brain and unilateral head and neck tumors.
    Gu W; O'Connor D; Nguyen D; Yu VY; Ruan D; Dong L; Sheng K
    Med Phys; 2018 Apr; 45(4):1338-1350. PubMed ID: 29394454
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A single-field integrated boost treatment planning technique for spot scanning proton therapy.
    Zhu XR; Poenisch F; Li H; Zhang X; Sahoo N; Wu RY; Li X; Lee AK; Chang EL; Choi S; Pugh T; Frank SJ; Gillin MT; Mahajan A; Grosshans DR
    Radiat Oncol; 2014 Sep; 9():202. PubMed ID: 25212571
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of respiratory motion on passively scattered proton therapy versus intensity modulated photon therapy for stage III lung cancer: are proton plans more sensitive to breathing motion?
    Matney J; Park PC; Bluett J; Chen YP; Liu W; Court LE; Liao Z; Li H; Mohan R
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):576-82. PubMed ID: 24074932
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intensity modulated proton arc therapy via geometry-based energy selection for ependymoma.
    Cao W; Li Y; Zhang X; Poenisch F; Yepes P; Sahoo N; Grosshans D; McGovern S; Gunn GB; Frank SJ; Zhu XR
    J Appl Clin Med Phys; 2023 Jul; 24(7):e13954. PubMed ID: 36913484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.